Violacein cytotoxicity on human blood lymphocytes and effect on phosphatases

References

• Rettori D, Durán N. Production, extraction and purification of violacein: an antibiotic pigment produced by Chromobacterium violaceum. World J Microb Biot 1998; 14: 685–688
   Web of Science ®Google Scholar
• Bromberg N, Durán N. Violacein transformation by peroxidases and oxidases: implications on its biological properties. J Mol Catal B-Enzym 2001; 11: 463–467
   Google Scholar
• Lichstein HC, Van de Sand VF. Violacein, an antibiotic pigment produced by Chromobacterium violaceum. J Infec Dis 1945; 76: 47–51
   Web of Science ®Google Scholar
• Durán N, Erazo S, Campos V. Bacterial Chemistry-II: antimicrobial photoproduct from pigment of Chromobacterium violaceum. An Acad Bras Cien 1983; 55: 231–234
   Web of Science ®Google Scholar
• Haun M, Pereira MF, Hoffman ME, Joyas A, Campos V, Filardi LDS, De Castro SL, Durán N. Bacterial chemistry VI. Biological activities and cytotoxicity of 1, 3-dihydro-2H-indol-2-one derivatives. Biol Res 1992; 25: 21–25
   PubMedGoogle Scholar
• Durán N, Antônio RV, Haun M, Pilli RA. Biosynthesis of a Trypanocide of Chromobacterium violaceum. World J Microb Biot 1994; 10: 686–689
   PubMed Web of Science ®Google Scholar
• De Souza A, Aily DCG, Sato DN, Durán N. Atividade da Violaceína in vitro sobre Mycobacterium tuberculosis H37RA. Rev Inst Adolfo Lutz 1999; 58: 59–62
   Google Scholar
• Andrighetti-Frohner CR, Antonio RV, Creczynski-Pasa TB, Barardi CRM, Simões CMO. Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacterium violaceum. Mem Inst Oswaldo Cruz 2003; 98: 843–848
   PubMed Web of Science ®Google Scholar
• Durán N, Justo GZ, Melo PS, De Azevedo MBM, Souza-Brito ARM, Almeida ABA, Haun M. Evaluation of the antiulcerogenic activity of violacein and its modulation by the inclusion complexation with β-cyclodextrin. Can J Physiol Pharm 2002; 81: 387–396
   Web of Science ®Google Scholar
• Melo PS, Justo GZ, Xavier AL, De Azevedo MBM, Durán N, Haun M. Apoptosis induction by free co-formulated violacein in HL60 human promyelocytic leukemia cells. FASEB J 2001; 15: A172
   Web of Science ®Google Scholar
• Melo PS, Justo GZ, De Azevedo MBM, Durán N, Haun M. Violacein and its beta-cyclodextrin complexes induce apoptosis and differentiation in HL60 cells. Toxicology 2003; 186: 217–225
   PubMed Web of Science ®Google Scholar
• Melo PS, Maria SS, Vidal BC, Haun M, Durán N. Violacein cytotoxicity and induction of apoptosis in V79 cells. In vitro Cell Dev B 2000; 36: 539–543
   Web of Science ®Google Scholar
• Durán N, Menck CFM. Chromobacterium violaceum: A review of pharmacological and industrial perspectives. Crit Rev Microbiol 2001; 27: 201–222
   PubMed Web of Science ®Google Scholar
• Ferreira CV, Bos CL, Versteeg HH, Justo GZ, Duran N, Peppelenbosch MP. Molecular mechanism of violacein-mediated human leukemia cell death. Blood 2004; 104: 1459–1464
   PubMed Web of Science ®Google Scholar
• Zolnierowicz S. Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem Pharmacol 2000; 60: 1225–1235
   PubMed Web of Science ®Google Scholar
• Garcia A, Cayla X, Guergnon J, Dessauge F, Hospital V, Rebollo MP, Fleischer A, Rebollo A. Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis. Biochimie 2003; 85: 721–726
   PubMed Web of Science ®Google Scholar
• Zhang ZY. Protein tyrosine phosphatases: prospects for therapeutics. Curr Opin Chem Biol 2001; 5: 416–423
   PubMed Web of Science ®Google Scholar
• Davidson D, Veillette A. PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocytes activation by targeting a unique set of substrates. EMBO J 2001; 20: 3414–3426
   PubMed Web of Science ®Google Scholar
• Harrod TP, Justement LB. Evaluating function of transmembrane protein tyrosine phosphatase CD148 in lymphocyte biology. Immunol Res 2002; 26: 153–166
   PubMed Web of Science ®Google Scholar
• Ma XZ, Jin T, Sakac D, Fahim S, Zhang X, Katsman Y, Bali M, Branch R. Abnormal splicing of SHP-1 protein tyrosine phosphatase in human T cells: Implications for lymphomagenesis. Exp Hematol 2003; 31: 131–142
   PubMed Web of Science ®Google Scholar
• Mustelin T, Vang T, Bottini N. Protein tyrosine phosphatases and the immune response. Nature Rev Immunol 2005; 5: 43–57
   PubMed Web of Science ®Google Scholar
• Sodeoka M, Baba Y. Development of protein phosphatases inhibitors: A focused library approach. J Syn Org Chem Jpn 2001; 59: 1095–1102
   Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63
   PubMed Web of Science ®Google Scholar
• Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications of the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89: 272–277
   Web of Science ®Google Scholar
• Aoyama H, Melo PS, Granjeiro PA, Haun M, Ferreira CV. Cytotoxicity of okadaic acid and kinetic characterization of protein tyrosine phosphatase activity in V79 fibroblasts. Pharm Pharmacol Commun 2000; 6: 331–334
   Google Scholar
• Hartree EF. Determination of protein: A modification of the Lowry method that gives a linear photometric response. Anal Biochem 1972; 48: 422–427
   PubMed Web of Science ®Google Scholar
• Freire ACG, Aoyama H, Haun M, Ferreira CV. Relationship between phosphatase activity and cytotoxic effect of two protein phosphatase inhibitors, okadaic acid and pervanadate, on human myeloid leukemia cell line. J Enz Inhib Med Chem 2003; 18: 425–429
   PubMed Web of Science ®Google Scholar
• Freire ACG, Melo PS, Aoyama H, Haun M, Durán N, Ferreira CV. Cytotoxic effect of the diterpene lactone dehydrocrotonin from Croton cajucara on human promyelocytic leukemia cells. Planta Med 2003; 69: 67–69
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Dixon JE. Active site labeling of the Yersinia protein tyrosine phosphatase: The determination of the pKa of the active site cysteine and the function of the conserved histidine 402. Biochemistry 1993; 32: 9340–9345
   PubMed Web of Science ®Google Scholar
• Jones PA, Bracher M, Marenus K, Kojima H. Performance of the neutral red uptake assay in the COLIPA international validation study on alternatives to the rabbit eye irritation test. Toxicol In Vitro 1999; 13: 325–333
   PubMed Web of Science ®Google Scholar
• Rodriguez JA, Haun M. Cytotoxicity of transdehydro-crotonin from Croton cajucara on V79 cells and rat hepatocytes. Planta Med 1999; 65: 522–526
   PubMed Web of Science ®Google Scholar
• Berridge MV, Tan AS. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 1993; 303: 474–482
   PubMed Web of Science ®Google Scholar
• Zhang M, Moran M, Round J, Low TA, Patel VP, Tomassian T, Hernandez JD, Miceli MC. CD45 signals outside of lipid rafts to promote ERK activation, synaptic raft clustering, and IL-2 production. J Immunol 2005; 174: 1479–1490
   PubMed Web of Science ®Google Scholar
• Schmidt A, Rutledge SJ, Endo N, Opas EE, Tanaka H, Wesolowski G, Leu CT, Ramachandaran C, Rodan SB, Rodan GA. Protein-tyrosine phosphatase activity regulates osteoclast formation and function: Inhibition by alendronate. Proc Natl Acad Sci 1996; 93: 3068–3073
   PubMed Web of Science ®Google Scholar
• McAllister TN, Du T, Frangos JA. Fluid shear stress stimulates prostaglandin and nitric oxide release in bone marrow-derived preosteoclast-like cells. Biochem Biophys Res Commun 2000; 270: 643–6448
   PubMed Web of Science ®Google Scholar